IL1B and COVID-19: Studies have shown that S-protein in SARS-CoV-2 could elicit inflammasome formation and IL-1β production in macrophages from COVID-19 patients, and further exploration revealed that this process needed non-specific activation of monocytes in vivo to trigger NLRP3 inflammatory signaling (40).